To explore the advantages of interventional vascular embolization in the treatment of traumatic hepatic and spleen rupture and to evaluate its clinical value.

Randomized controlled 82 cases of traumatic patients with liver and spleen rupture in Shenzhen Baoan District Fuyong People’s Hospital from May 2010to May 2016, Including 49 males and 33 females, aged 18 to 55 years, mean age was (32.5±4.5) years. According to the random number rule, the patients were divided into interventional embolization group and surgical treatment group, 41 cases in each group. On the basis of conventional basic therapy, patients undergoing interventional embolization were treated with vascular interventional vascular embolization, and patients in the surgical treatment group received surgical treatment. After surgery, Comparison of differences about Operation time, intraoperative blood loss, hospitalization time, serum alanine aminotransferase (ALT) level, time to start eating, the success rate of one-time hemostasis and the incidence of adverse reactions (rebleeding, infection, fever) so on.

There was no significant difference in the operation time between the two groups (P>0.05). Compared with the surgical treatment group, Interventional embolization in patients with less bleeding[(65.98±10.56)mL vs(354.74±20.47)mL], shorter hospital stay and start eating time[(6.98±2.45)d vs(12.78±4.68)d; (3.24±0.75)d vs(6.74±2.47)d], high serum ALT levels[(43.46±6.95)U/L vs(23.28±5.43)U/L], high success rate of one-time hemostasis[100%(41/41)vs 85.36%(35/41)], adverse reaction rate was low[4.88%(2/41)vs 24.39%(10/41)], the difference was statistically significant (P<0.05).

Interventional vascular embolization is a safe and effective treatment for patients with traumatic hepatic and splenic rupture. It is worthy to be popularized because of its advantages such as less operative trauma, less complication rate, better curative effect, and higher safety.